Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials.
J Oncol Pharm Pract
; 26(4): 861-865, 2020 Jun.
Article
em En
| MEDLINE
| ID: mdl-31566113
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Piridinas
/
Carcinoma de Células Renais
/
Inibidores de Proteínas Quinases
/
Neoplasias Renais
/
Anilidas
Tipo de estudo:
Evaluation_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article